Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Recruiting · NCT05693766 · Registry updated 2026-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, invasive breast carcinoma, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-01-20 | NCT05693766 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Agendia | 4 |
| Sonya Reid | 1 |
| Susan G. Komen Breast Cancer Foundation | 16 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Alabama Birmingham | Birmingham | United States | 4 |
| UT Southwestern Medical Center | Dallas | United States | 210 |
| Vanderbilt University/Ingram Cancer Center | Nashville | United States | 259 |